Summary
Introduction
One approach to schizophrenia has been to divide schizophrenic subjects into populations with a presumed high genetic risk (familial schizophrenia) and those with a low genetic risk (sporadic schizophrenia) (Murray et al., 1985) . The purpose of such a division is not to try to define schizophrenic 'subtypes', as has been suggested by some critics (Roy and Crowe, 1994) , but rather to produce populations which are enriched or depleted in terms of genetic risk. There has been considerable recent interest in the possibility that sporadic schizophrenia may be a manifestation of prenatal environmental factors (Murray and Jones, 1996) rather than simply the rare expression of a lower genetic risk. This might be reflected in phenotypic differences between sporadic and familial subjects.
A survey of studies comparing familial and sporadic schizophrenia suggests that there may be neurological differences between populations defined in this way (Roy and Crowe, 1994) . Early neurological studies of patients with
© Oxford University Press 1998 (ii) the pattern of abnormality is different in familial and sporadic schizophrenic subjects, and (iii) the well relatives of familial (but not sporadic) schizophrenic subjects will show neurological abnormalities. An excess of primary signs compared with the controls was demonstrated in the sporadic schizophrenic group only. Both the familial schizophrenics and their first-degree relatives (but not their sporadic counterparts) showed an increase in integrative signs. The results support the existence of different mechanisms of underlying brain dysfunction in familial and sporadic schizophrenia.
schizophrenia showed that signs could be demonstrated in the absence of a recognized underlying neurological diagnosis (Tucker et al., 1974; Quitkin et al., 1976) . These studies examined a mixture of localizing neurological signs such as the plantar response, as well as tests of motor co-ordination and sensory integration. Signs demonstrated in these studies were designated 'soft signs' because of the absence of known accompanying focal structural pathology. In later studies, the term 'soft sign' has been used more restrictively for signs which do not suggest primary tract or nucleus pathology, as opposed to 'hard signs', which do . The variation in the signs examined in different studies, and the use of the terms 'hard' and 'soft' to describe different combinations of signs, makes evaluation of previous work extremely difficult. Moreover, the term 'soft sign' implies that the signs sought are not acceptable in classical neurology and cannot be defined with any rigour; this is not the case.
In this study systematic neurological examination of patients with schizophrenia was carried out using a schedule in which signs were divided prospectively into primary and integrative signs. The purpose of this division was to group neurological signs into those with a tendency to reflect focal abnormality and those with a tendency to reflect more diffuse brain processing. Primary signs are elicited by a standard neurological examination whilst integrative signs are likely to depend on integration of, or between, motor and sensory processing. The integrative schedule was based on the most rigorously defined and validated neurological instrument that has been previously used in schizophrenia (Buchanan and Heinrichs, 1989) . The previous schedule does not include the primary measures also investigated here. We used this neurological assessment, first, to test the hypothesis that neurological abnormalities exist in schizophrenia. Secondly, we investigated the pattern of neurological abnormality in familial and sporadic schizophrenic subjects, as a test of the hypothesis that the phenotype is different in these two populations. Finally, we examined the same neurological features in the well first-degree relatives of the familial and sporadic schizophrenic subjects, to test the hypothesis that a neurological abnormality is transmitted through families multiply affected with schizophrenia.
A particular difficulty with neurological studies of schizophrenia is the effect of confounding factors such as antipsychotic drugs. In this study we used the technique of logistic regression to investigate differences in the expression of neurological abnormalities between groups. This technique allows group differences to be sought whilst taking into account the effect of any confounding variables. The technique does not assume a particular data distribution and is useful where the data are skewed, as in this study.
Methods

Group definitions and psychiatric assessment
The study population comprised 214 subjects divided into five groups: (i) subjects with schizophrenia from multiply affected families; (ii) their first-degree relatives; (iii) subjects with schizophrenia without a family history (sporadics); (iv) first-degree relatives of sporadic schizophrenic subjects, and (v) normal controls. All subjects gave informed consent. All subjects in the study had a psychiatric diagnosis made by a single psychiatric rater (T.S.), using the structured interview SADS-L (Spitzer and Endicott, 1978) carried out on the same day as the neurological assessment. The psychiatric assessor was blind to family status and any previous psychiatric diagnosis at the time of the assessment, and was provided only with a patient identification number. Further information was later obtained from informants and case-note review to enable a DSM-IIIR (American Psychiatric Association, 1987) diagnosis to be made. The schizophrenic subjects in the familial and sporadic groups all met DSM-IIIR criteria for schizophrenia. Four subjects from the multiply affected families had chronic psychoses which did not meet DSM-IIIR criteria for schizophrenia, and were excluded from the analysis (two cases of schizoaffective disorder, one case of psychosis not otherwise specified, and one case of bipolar disorder). Exclusion criteria for all groups included significant head injury (with period of anterograde amnesia lasting 24 h), prolonged febrile convulsion or ongoing seizure disorder, and alcohol or drug dependency as defined in DSM-IIIR. Three subjects included in the study had a lifetime history of fewer than three generalized seizures (one subject each in the two relative groups and the familial schizophrenic group).
The multiply affected family members were recruited for the Maudsley Family Study from centres throughout the UK. Multiply affected families are defined as families containing at least two schizophrenic members who are first-or seconddegree relatives, where the diagnosis of schizophrenia is confirmed by interview for this study or by a psychiatrist at another centre. Twenty families satisfied this strict definition of a multiply affected family. Two other families did not meet this strict criterion, but included two members who were first-degree relatives, one of whom had schizophrenia and one of whom had schizoaffective disorder. The schizophrenic subjects in the sporadic group were defined as having no evidence of psychotic illness in first-or seconddegree relatives, and the normal control subjects all met this criterion.
Neurological assessment
Neurological assessments were carried out on the 214 subjects by a single neurological assessor (T.D.G.) over a period of 2 years. The assessor was blinded to subject diagnosis and family status, and was provided with only a subject identification number at the time of the assessment. A structured schedule was used in a stereotyped order using the measures in Table 1 . A scoring instrument was used to assign a value of 0, 1 or 2 to each of the measures in the schedule, where 0 represents no abnormality, 2 represents a score at or above a reference criterion regarded as clearly abnormal, and 1 represents an intermediate criterion. The schedule is divided into tests of primary neurological dysfunction and tests of integrative neurological dysfunction. 'Primary neurological dysfunction' means dysfunction identified by a standard neurological examination including cranial nerve and eye movement examinations, lateralizing limb pyramidal signs and frontal release signs. 'Integrative neurological dysfunction' means abnormality of function which is likely to depend on integration within the motor and sensory systems or between the motor and sensory systems. Integrative dysfunction was separated in this way to define a group of functions which may depend on distributed processing, and is not used as a synonym for 'executive' or presumed frontal lobe dysfunction. The term 'soft sign' is not used in this paper, with its implication that the signs are not defined with any rigour and are acceptable in classical neurology. However, the primary measures used broadly correspond to 'hard signs' used in previous studies (e.g. Woods et al., 1991) and the integrative signs include 
Measures were all assessed using an instrument which divided measures into 0 (completely normal), 1 or 2 (markedly abnormal). For the integrative measures the same rating scale was applied as in Buchanan and Heinrichs (1989) to allow comparison. This instrument was extended in the present study to give ratings of 0-2 for primary measures not included in the previous instrument. The main analysis in this paper used all measures. The measures in shown bold type were used in a further analysis which used a more restrictive definition of primary and integrative (see text).
measures previously defined as 'soft signs'. The same scoring measures as in the instrument of Buchanan and Heinrichs were used for common measures, to allow comparison with previous studies using that rigorously defined instrument. However, that instrument does not include the primary assessment used here.
Previous neurological studies of schizophrenia have included a smaller number of either primary or integrative signs or a mixture of the two. In the present study an attempt was made to classify all signs as either primary or integrative, rather than excluding large numbers of signs. There were, however, some signs that were difficult to classify as either primary or integrative. For example, the fist-ring, fist edgepalm test and Oszersetski test involve complex motor sequencing and the use of proprioceptive and visual feedback and therefore fulfil the definition of integrative sign given above. However, these tasks are impaired in damage to the frontal lobes and might also be regarded as focal signs. Similarly, many of the signs involving sensory integration have been localized to the parietal cortices. In the cases of both the frontal-sequencing signs and signs involving sensory integration, the likely occurrence of convergent processing in one particular area of association cortex was not seen to be a reason to exclude these signs from the integrative schedule. Classical 'frontal release' signs, on the other hand (snout, grasp and suck), were classified as primary signs on the basis of being phenomena dependent on the release of motor routines, likely to be localized, and not dependent on sensorimotor integration. Other signs which were difficult to classify were the tandem walk and finger-nose tests, which were included in the integrative part of the schedule. Both may be abnormal in focal cerebellar damage, but can also be affected by conditions in which co-ordination between sensory input and motor output is affected, as in deafferentation due to certain ganglionopathies.
Separate measures were carried out to assess the extrapyramidal side-effects of drugs. The Abnormal Involuntary Movement in Schizophrenia (AIMS) scale (National Institute of Mental Health, 1974) and the Targeting of Abnormal Kinetic Effects (TAKE) scales (Wojcik et al., 1980) were used as measures of extrapyramidal effects due to drugs in the schizophrenic groups, though these are recognized as being imperfect instruments. These measures were also carried out on the non-schizophrenic groups. AIMS and TAKE did not form part of the assessment of primary and integrative measures.
A measure of rating consistency within and between raters was obtained by making video tapes of 17 of the examinations, which were regraded without the original data by the same rater and by a blinded second neurologist 1 year after the original examination (Appendix 1). This allowed assessment of only the 'visual' ratings; many of the primary signs could not be assessed in this way.
Analysis
The frequency of individual abnormalities was compared across the groups, and scores for the primary, integrative and total abnormalities were calculated by adding the individual scores for the measures in Table 1 . The distribution of the primary, integrative and total neurological scores was assessed overall and for the individual subject groups, and the effects of the variables age, sex, social class, handedness, premorbid IQ and drugs was assessed. The distribution of both primary and integrative abnormalities was found to be highly skewed. Logarithmic and other transformations of the data did not yield a normal distribution of the data. Non-parametric analysis was therefore employed to compare the frequencies of neurological abnormalities between the groups.
The overall effect of group without correction for confounding variables was first assessed using the KruskalWallis test. A detailed analysis was then carried out to assess the differences between the normal control group and each of the test groups using logistic regression (Altman, 1991) to control for confounding variables. The primary and integrative scores for each subject were first dichotomized into normal and abnormal using broad and narrow criteria for neurological abnormality. Narrow criteria represent a conservative estimate of abnormality which is met by a small proportion of the normal group (~2% for the primary and integrative scores), whilst Notes: (i) values are expressed as mean and standard deviation if these are normally distributed and range for non-normally distributed variables; (ii) P value is based on statistical tests appropriate to the nature of variables; (iii) social class is expressed as the proportion of patients in classes 1-3 compared with the total in classes 1-6 (for the schizophrenic patients the social class of the parents was used); (iv) premorbid IQ is the estimated global IQ based on the National Adult Reading Test (Nelson, 1982) ; (v) handedness is the percentage of subjects who are strongly right-handed [scoring 12 right on the 12 point classification by Annett (1970) assessed by T.D.G. before the neurological assessment)]; (vi) the last row gives the mean drug dose in chlorpromazine equivalents [calculated as in Baldessarini et al. (1984) and Davis (1976) ]. L right; R right. * t test; † analysis of variance; ‡ χ 2 test; § Mann-Whitney U exact two-tailed test.
broad criteria are based on a less conservative threshold for abnormality. The different criteria were used to investigate the effect of threshold criteria on the demonstration of differences between the groups. Using these criteria, the frequency of neurological abnormalities was compared between the groups using logistic regression to control for the confounding variables age and social class. Separate regression analyses were carried out for the comparison of each of the subject groups with the control groups, to allow calculation of an odds ratio, and a probability value for the odds ratio being different from 1. The odds ratio represents a measure of the estimated probability of subjects with neurological abnormality being in the relevant non-control group in relation to those with no neurological abnormality. This is also expressed in the results as a significance level for neurological abnormality for each comparison carried out. Analysis was also carried out based on a more exclusive definition of primary and integrative using the measures shown in bold type in Table 1 . Extrapyramidal signs, 'frontal release' signs and cerebellar signs were excluded from this analysis.
The analysis was also extended to look for a group by sex effect. The purpose of this was to look for variation in differences between the groups with respect to sex; theories of neurodevelopmental schizophrenia suggest an increase in susceptibility in male sporadic cases, and a review of structural brain studies using CT suggests that males show the most marked differences between the sporadic and familial groups (Murray and Jones, 1996) . Table 2 shows the demographic characteristics for the groups. There were no significant differences in sex, years in education, social class or handedness between the groups. The significant difference in age between the groups is due to the relatives of the schizophrenic subjects being older, these groups containing a high proportion of parents of schizophrenic patients. Age was found to be a significant confounder for the integrative score and was taken into account in subsequent analysis. Premorbid IQ was also significantly different between the groups, but was specifically not taken into account in the group comparison in view of the evidence that the premorbid IQ of schizophrenic subjects is lower than that of the general population (Bower et al., 1960; Watt and Lubensky, 1976) . Table 3 shows the individual measures in the groups, and is striking for the low frequency of all signs compared with previous studies (e.g. Heinrichs and Buchanan, 1988) . Amongst the primary measures, broken smooth pursuit was increased in the schizophrenic groups. Abnormalities of smooth pursuit have received attention in schizophrenia as a possible biological marker, using a more detailed assessment in specialist eye laboratories than that used here (Schlenker et al., 1994) . Chorea was increased in both schizophrenic groups and also in the group of relatives from families multiply affected with schizophrenia. Postural limb tremor was increased in both schizophrenic groups. Amongst the classical frontal release signs, glabellar tap was increased in both schizophrenic groups, and snout in both schizophrenic groups and in relatives of schizophrenic subjects, though no subjects demonstrated a grasp reflex, even with distraction. Amongst the integrative scores, abnormalities of motor sequencing (fist-ring test, fist edge-palm test and Oszeretski) were increased in both groups of schizophrenics and relatives of schizophrenic subjects compared with the control group, as was the case for audiovisual integration, graphaesthesia and extinction. Right-left confusion was relatively common, even in the normal subjects. As our aim was to look at the differences in overall primary and integrative scores between the groups, significance levels were not calculated for the distribution of individual measures. The distributions of the individual scores and of the composite primary and integrative scores were highly skewed: further analysis was carried out using non-parametric methods rather than analysis of variance.
Results
Group demographics and group matching
Prevalence and distribution of individual neurological abnormalities
5 0 7 0 Smooth pursuit 24 9 25 7 0 Saccade target 0 0 0 0 0 Saccade command 0 0 0 0 0 Synkinesis 0 0 11 2 0 Convergence 0 7 0 Tone increase R 3 0 7 0 0 Tone increase L 3 0 7 0 0 Hypereflexia R 3 0 0 0 2 Hypereflexia L 3 0 0 0 2 Plantar R 3 0 4 0 0 Plantar L 3 0 4 0 0 Romberg 3 0 0 2 0 Chorea R 6 6 11 0 2 Chorea L 6 6 7 0 2 Tremor R 6 2 14 2 0 Tremor L 3 2 18 2 0 Mirror
Effects of age, sex, social class, handedness and drugs on the neurological scores
Age had a significant effect on the neurological measures; a linear relationship between age and both integrative and total number of abnormal signs was found. Social class also had a significant effect on the primary and integrative measures. These confounders were taken into account in the group comparisons. Sex and handedness did not have a significant effect on the neurological measures. Drug dose was not a significant confounder for the primary, integrative or total neurological scores in the schizophrenic groups.
Consistency within and between raters
Appendix 1 lists the agreement rates for the measures that could be assessed using video tapes of the original examination. Proportional agreement rates rather than kappa scores were used, as the former provide a more helpful measure for comparison with studies on neurological populations with a higher prevalence of abnormality. Withinrater agreement rates for the individual measures varied from 0.85 to 1.0 and between-rater agreement rates varied from 0.64 to 1.0, the poorest agreement occurring for eye movement abnormalities and motor sequencing tasks. The inter-observer agreement rates were similar to those found in previous studies of agreement between neurologists on the presence of neurological signs (e.g. Hansen et al., 1994) . Figure 1 shows the distribution of individual scores in each group and demonstrates the skewed distribution and differences in the proportion of abnormal subjects between the groups. Non-parametric analysis using the Kruskal-Wallis test showed a significant effect of group on both the primary (P 0.01) and the integrative (P 0.01) score. This preliminary analysis does not take into account the effect of confounding variables between the groups; further testing was carried out to examine differences in the expression of abnormal signs between the test groups and the normal control group using logistic regression to control for confounding variables. Table 4 shows the distribution of primary and integrative abnormalities between the groups expressed as the proportion of each group fulfilling broad and narrow definitions of abnormality. Odds ratios are also shown for the comparison between the proportion of abnormal subjects in each group with the normal control group.
Group comparison: primary and integrative measures
For the primary abnormalities a narrow definition of abnormality was used which defined 2.1% of the control population as abnormal (primary score of 3). Using this definition of abnormality a significant proportion of abnormal subjects was demonstrated only in the sporadic schizophrenic group (21%). A broad definition of primary abnormality was also used which defined 15% of the normal control group as abnormal (primary score of 1). Using the broader definition of abnormality a significant proportion of subjects in both the sporadic and familial schizophrenic groups were defined as abnormal (57 and 39%, respectively).
For the integrative abnormalities a narrow definition of abnormality defined 2.1% of the normal group as abnormal (integrative score of 3). Using this narrow definition, both groups of schizophrenic patients and both relative groups showed a significant increase in the proportion of abnormal subjects (within the range 25-50%). A broad definition of abnormality defined 23% of the control group as abnormal (integrative score 2). Using this broad definition of abnormality the familial schizophrenic group and the group of familial schizophrenic relatives showed significant increases in the proportion of abnormal subjects (67 and 47%, respectively). The proportion of abnormal subjects in the sporadic schizophrenic and sporadic relative group was not abnormal using the broad criterion.
Analysis using the more restricted definition of primary and integrative abnormality based on the measures shown in bold type in Table 1 yielded the same result. Logistic regression was carried out based on the same confounding variables. Using a definition of abnormality defining 2% of the control population as abnormal, primary neurological scores were significantly different from the control group in the sporadic schizophrenic group only (odds ratio 13.8, confidence interval 1.6-122). Using a definition of abnormality defining~10% of the control population as abnormal, integrative neurological scores were only significantly different from the control group in the familial schizophrenic group (odds ratio 12.1, confidence interval 1.6-23) and the familial schizophrenic relative group (odds ratio 3.0, confidence interval 1.0-9.3).
Further analysis for the presence of group by sex interaction did not show a significant effect on the primary or integrative scores. Six obligate carriers were identified; no clear pattern of abnormality was suggested and statistical analysis was not indicated on a sample of this size.
Discussion
Frequency of individual abnormalities
A striking feature of this study compared with previous studies of neurological abnormality in schizophrenia is the overall low frequency of abnormal individual neurological signs in all groups. For example, fewer than 4% of subjects in any group were found to have abnormality of fingernose testing compared with values of 18% in one study (Buchanan and Heinrichs, 1989) , even in the control group using the same scoring instrument for that measure. Part of the difference may be due to the attribution of equivocal signs; the assessor in this study always scored a sign as the lower value if it was between 0 and 1 or between 1 and 2. This is in accordance with standard neurological practice in Odds ratios are for the comparison of the proportion of abnormal subjects in group compared with normal control group and are adjusted for the confounding variables age and social class. *P 0.05; **P 0.01; ***P 0.005.
the UK, where the question addressed in any neurological consultation is 'is there a clear neurological abnormality or not?' rather than 'could there possibly be a neurological abnormality present?' We suggest that a frequency of abnormal finger-nose testing of 4% in a normal control sample would be more acceptable to most practising neurologists. Other previous studies have used less conservative estimates of neurological abnormality: for example, Cox and Ludwig (1979a) consider that 'to some extent these high individual percentages are somewhat artificial because of lenient criteria by which presence or absence was determined.'
Primary neurological abnormalities in the schizophrenic groups
Many of the early studies of neurological dysfunction in schizophrenia either looked for only one or two primary abnormalities, such as an upgoing plantar response or hearing loss, or did not include any. This has been a persistent pattern, and one of the currently most widely used and well-validated instruments for the evaluation of neurological signs in schizophrenia (Buchanan and Heinrichs, 1989) includes none of the primary signs used in this study. However, the designers of this instrument comment that it is designed to 'complement the traditional neurological instrument'. A minority of recent studies Kinney et al., 1992; Kinney et al., 1993) have looked at primary neurological abnormalities in schizophrenic patients and found an increase compared with normal controls and patients with affective disorder. In these studies the primary abnormalities were screened to exclude signs which were considered to be the result of drugs or neurological events occurring after the onset of psychiatric illness. Integrative neurological abnormalities were not examined systematically in these studies, as these were considered less specific. This was on the basis of other studies suggesting that these signs are also present in nonschizophrenic psychiatric disorders (Mukherjee et al., 1984; Hollander et al., 1990) and the possible contribution of drugs (Marsden, 1982) . In this study, using a narrow definition of primary abnormality, the group of sporadic schizophrenic patients was shown to contain a significantly increased proportion of abnormal subjects. There are good grounds for preferring a narrow definition of abnormality for primary signs, on the basis that a standard clinical examination of cranial nerve, eye signs, lateralizing limb pyramidal signs and frontal release signs would be expected to define only a small proportion of control populations as abnormal. The increase in primary abnormalities in the group of sporadic schizophrenic patients is in accordance with studies showing that early neurological events are over-represented in this group (Lewis and Murray, 1987; Lyon et al., 1989; Geddes and Lawrie, 1996) .
Previous studies of primary abnormality in schizophrenia used a criterion which defined up to 15% of the control population as abnormal in one study , though the difference between schizophrenic and control populations was also demonstrated in an earlier study where 4% of the control population were defined as abnormal . When a broad criterion of abnormality is used in the present study, as in the earlier studies, both schizophrenic groups with and those without a family history of schizophrenia show a significant excess of abnormal subjects. This study therefore agrees with the previous studies suggesting an increase in primary abnormalities in schizophrenia, though only in the sporadic group using the narrow criterion. The study also agrees with previous ones about the effects of age and sex on primary abnormality, which were not found to be significant confounders.
Integrative neurological abnormalities in the schizophrenic groups
There has been considerable recent interest in the concept of schizophrenia as a disorder of integration of anatomically distinct brain functions, or functional connectivity (Friston and Frith, 1995) . The concept is supported by functional imaging studies (Frith, 1995) and by studies of EEG coherence (e.g. Kaiser and Gruzelier, 1996) . Careful pathological studies (Selemon et al., 1995) showing a global increase in cortical cell density in schizophrenia, suggesting a decrease in neuropil and therefore dendritic arborization, are also consistent with this concept, as would be the frequent presentation of metachromatic leucodystrophy with a schizophrenia-like illness (Galbraith et al., 1989; Hyde et al., 1992) . The concept is not new; Wernicke (1906) described psychosis as a dysfunction of an organ of organization, meaning long corticocortical fibres, whilst the term schizophrenia itself was introduced by Bleuler to convey the concept of a splitting of mental faculties. The term 'neurointegrative disorder' has been used for some time in a slightly different sense, in children at high genetic risk for the later development of schizophrenia, to refer to erratic neurological development (Fish, 1957 (Fish, , 1959 (Fish, , 1977 Fish et al., 1965; Fish and Hagin, 1973) . Later studies have not shown the same degree of fluctuation in neurological performance in such infants using different assessment and statistical methods (Marcus, 1974; Marcus et al., 1981) , though the presence of neurological deficits has been corroborated. A study of a cohort of 4746 children not selected because of high risk demonstrated abnormalities of motor and speech development in the 30 subjects who later developed schizophrenia (Jones et al., 1994) . The paediatric literature is plagued by the same confusion as the schizophrenia literature caused by the use of the term 'soft sign', but in general these studies identify mainly nonprimary signs.
In this study signs likely to depend on integration within and between the motor and sensory systems were analysed separately from primary signs. This was in an effort to define signs reflecting distributed cortical processing, though a deficit in these functions need not necessarily be due to a distributed deficit; a focal lesion at one point in a cortical network can have the same effect. Most of the previous studies of neurological abnormality in schizophrenia have included integrative signs, often exclusively (Tucker et al., 1974; Cox and Ludwig, 1979a, b; Johnstone and Owens, 1980; Torrey, 1980; Manschreck et al., 1981; Walker and Green, 1982; Kolakowska et al., 1985; Liddle, 1987; Gureje, 1988; Awad, 1989; Buchanan et al., 1990; Johnstone et al., 1990; Merriam et al., 1990; Rossi et al., 1990; King et al., 1991; Schroder et al., 1992; Saunders et al., 1994; Gupta et al., 1995; Clair and Boschen, 1996; Clair and Mann, 1996) . The studies are difficult to compare directly because of different methodology and patient groups, but some general findings emerge. First, in the studies where schizophrenics have been compared with normal control groups they often show an increase in integrative neurological signs. Frequencies reported for individual signs vary (indeed, whether or not individual signs are reported at all varies), but values of~50% of subjects positive for signs such as graphaesthesia are not uncommon. The possible contribution of neuroleptic drugs to the findings is addressed in some studies by the concurrent use of extrapyramidal rating scales as an implied measure of neuroleptic effect (e.g. Manschreck et al., 1982) , whilst studies of first-break schizophrenic subjects suggest a pre-existing neurological deficit (e.g. Sanders et al., 1994; Gupta et al., 1995) . The presence of neurological signs has been associated with tardive dyskinesia (Wegner et al., 1985; King et al., 1991) and with cognitive deficit (Kolakowska et al., 1985; King et al., 1991; Flashman et al., 1996) . Some studies have shown an increase in neurological abnormalities with increasing age (Tucker et al., 1974; Torrey, 1980) . Many studies suggest an increase in neurological signs in chronic as opposed to acute schizophrenia (e.g. Torrey, 1980) , whilst the relevance of neurological signs to prognosis is unclear (Kolakowska et al., 1985; Awad, 1989; Johnstone et al., 1990) . Studies looking at the lateralization of abnormalities have not produced consistent findings (Torrey, 1980; Walker and Green, 1982) .
In the present study, using a broad definition of abnormality, the familial schizophrenic group was shown to be significantly abnormal, but not the sporadic schizophrenic group. We suggest that the broader definition of abnormality, unlike the case for primary signs, does have face validity for integrative signs. The range of integrative signs used includes more subtle signs of brain dysfunction, which are abnormal in a larger proportion of non-patient populations than for the primary signs. The increased proportion of abnormal subjects in the schizophrenic subjects from multiply affected families is in accordance with the existence of a familial integrative abnormality. When a narrower definition of abnormality was used, both groups of schizophrenic subjects were found to have a significantly increased proportion of abnormal subjects. We therefore agree with previous studies on the presence of integrative abnormalities in schizophrenic subjects, though only in the familial schizophrenic group using what we believe to be a reasonable criterion of abnormality.
Drug effects and blinding in assessment of the schizophrenic groups
The effect of antipsychotic medication and difficulty in blinding are particular concerns in studies examining neurological abnormality in schizophrenic groups. In this study drug status was assessed in two ways. First, comparison of the drug doses thought to be taken by the subjects was assessed on the basis of subject and family history and, where possible, review of the subject records. These methods of assessing the drug dose prescribed are subject to error, and accurate information was not available for all of the subjects. Moreover, the drug dose prescribed is not always a good reflection of the drug dose taken, and it is difficult to convert the antipsychotic medication to an equivalent dose of chlorpromazine when this is given in various combinations of regular and depot medication. At least one of the subjects was on clozapine, which further complicates the calculation of equivalent drug dose, since atypical antipsychotic medications have a different pharmacological mechanism and side-effect profile to the older neuroleptics, particularly with respect to extrapyramidal side effects. An equivalent dose for this subject was not calculated.
A second measure of drug dosage was the use of the AIMS and TAKE scores as measures of extrapyramidal effect in the schizophrenic groups. These measures can be regarded as an additional test of the drug dose taken, at least in the subjects on traditional neuroleptic medication. However, in studies such as this, where different populations of schizophrenics were compared, it cannot be assumed that the sensitivity of the subjects will be equivalent. In particular, there is some evidence that schizophrenic subjects with more negative features of schizophrenia are more subject to extrapyramidal side effects (Johnstone and Owens, 1980 ) so that a difference in these features between the groups might lead to different expression of extrapyramidal signs.
Accepting these limitations of the measures of drug effect in the study, the comparison of prescribed drug doses has shown the two schizophrenic groups not to be significantly different from each other, and the AIMS and TAKE scores are similar in the two groups. The double dissociation of neurological abnormality in the schizophrenic groups for primary and integrative abnormality is not, therefore, consistent with a simple drug effect. If the primary abnormalities seen in the sporadic group were due to a general effect of drugs in schizophrenia, they should also have occurred in the familial group. Likewise, if integrative neurological abnormalities in the familial schizophrenic group were due to a general drug effect in schizophrenia, then they should have been increased in the sporadic group too. However, a different susceptibility to drug effects cannot be excluded by these data.
The hypothesis that drug effects contribute to the primary and secondary neurological scores was specifically tested in the analysis by logistic regression, where the possible confounding effect of drug dose was assessed, and not found to be significant for the primary or integrative scores. The technique of logistic regression represents a way of exploring drug effects on neurological data sets, and is a way of taking them into account in cases where they are demonstrated to be significant. Neurological data can potentially be affected by a number of variables, not all of which can be accommodated in experimental designs, and the technique of logistic regression allows these to be taken into account.
The issue of blinding is a second possible concern. The assessor was only given an identification number for each of the subjects, and spoke to the subjects as little as possible, but mannerisms, appearance and drug-related extrapyramidal features in psychotic individuals cannot be masked. Blinding to schizophrenic versus non-schizophrenic status cannot ever be complete in such a study. However, the degree of observer blinding to the two schizophrenic groups is likely to have been good. The presence of a double dissociation of neurological deficits shown in the two schizophrenic groups cannot therefore be attributed to blinding differences between the schizophrenic groups.
Neurological abnormalities and familial schizophrenia
Primary and integrative signs have been considered separately in this study as correlating with focal damage and disconnection respectively. In terms of underlying mechanism, perinatal or prenatal focal insult in sporadic schizophrenia (Lewis and Murray, 1987) could produce focal damage. A prediction based on this is that primary signs could occur in sporadic schizophrenia, but might be less likely to occur in familial schizophrenia. An underlying genetic brain disconnection predisposing to schizophrenia, on the other hand, might lead to an increase in integrative abnormalities in familial schizophrenics and their relatives. Previous studies have not supported these predictions, though no previous single study has looked systematically at primary and integrative signs in both types of family.
The effect of family history on the presence of primary abnormality in schizophrenic patients has been the subject of studies (Woods et al., 1987 showing an increase in focal signs in schizophrenic patients with, as opposed to those without, a family history of schizophrenia. This is the reverse of the finding in the present study. The sample size of family-history-positive schizophrenics in these studies was less than half that in the present study. The earlier studies also used a less conservative criterion for primary abnormality, and different individual measures. A study by the same group on non-schizophrenic relatives of schizophrenic patients who were selected on the basis of a positive family history also showed an increase in primary signs , again unlike the present study, using a total sample of familyhistory-positive schizophrenics and relatives under half that used here. An increase of primary neurological signs was also shown in non-schizophrenic relatives of schizophrenics not selected on the basis of a positive family history . That group argue for a familial tendency towards focal neurological abnormalities in both the multiply affected and sporadic groups, a hypothesis that is not supported by our data.
With respect to integrative abnormalities, most of the previous work on the relationship between family history of schizophrenia and the presence of abnormalities has been carried out on children at a high genetic risk for schizophrenia. These detailed, repeated studies of small numbers of children have shown neurological abnormalities to be present which might be compared with the integrative abnormalities studied here, though comparison between such different studies can only be made with extreme caution. It is of considerable interest, however, to note that the 'pandevelopmental' disorder described by Fish (1977) (meaning a maturational disorder which involves the brain) was present in one study in children who were high risk by virtue of family history, but not in children at high risk due to birth trauma. Moreover, there is a suggestion from some high-risk studies that the early deficits do correlate with sustained neurological dysfunction (Marcus et al., 1985) .
Few large studies of integrative dysfunction have been performed on adult schizophrenic patients and their relatives. One small study has shown a significant increase in mainly integrative abnormalities in schizophrenics from multiply affected families, but not sporadic schizophrenics, compared with normal and psychiatric controls (Walker and Shave, 1982) . This is in accordance with the present study. Another study of 58 schizophrenic patients not selected on the basis of family-history and only 31 relatives (Rossi et al., 1990) has shown an increase in predominantly integrative signs in both groups, unlike the case here. That study used a broad criterion for abnormality.
The importance of threshold criteria
This study suggests that the demonstration of differences in neurological function in groups with sporadic and familial schizophrenia depends on the threshold criteria used to define abnormality. When certain threshold criteria for abnormality are used the differences between the two schizophrenic groups are not apparent. Previous published studies have not used different thresholds of abnormality to investigate group differences. In view of the demonstrated effect, we suggest that thresholds are as important as the neurological measures themselves, and should be chosen with great care.
Conclusion
In this study a systematic neurological examination has shown abnormalities to be present in schizophrenic subjects compared with controls. This supports the concept of an underlying brain disorder in schizophrenia, which is no longer debated. By using clearly-defined populations which are enriched or depleted for genetic risk, and a systematic neurological instrument, a different pattern of abnormality has been shown in the two schizophrenic groups. Moreover, similar neurological abnormalities have been demonstrated in familial schizophrenic subjects and their non-psychotic first-degree relatives, in accordance with a familial deficit in distributed brain function. The study of well-defined schizophrenic populations with a systematic neurological instrument can therefore go further than simply providing supportive evidence for a brain disorder. The use of schedules based on small numbers of 'soft signs' in schizophrenia studies should be abandoned.
